MetaVia is trading at $1.67, up 5.59% in after-hours trading, with no confirmed company-specific catalyst identified.
- It closed at $1.58 on September 15, 2026.
- No confirmed September 15 announcement, earnings release, analyst action, or regulatory catalyst was identified; the latest clearly reported company news was September 9 preclinical DA-1726 data.
- The broader market was weaker, and the move may warrant rechecking for delayed disclosures.